138
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Patients with acute myocardial infarction and atrial fibrillation: association of anaemia with risk of in-hospital bleeding, stroke and other death causes

, , , , &
Pages 163-167 | Received 11 Aug 2020, Accepted 27 Dec 2020, Published online: 19 Jan 2021

References

  • Al Falluji, N., et al., 2002. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. American heart journal, 144 (4), 636–641.
  • Bikdeli, B., Abou Ziki, M.D., and Lip, G.Y.H., 2017. Pulmonary embolism and atrial fibrillation: two sides of the same coin? A systematic review. Seminars in thrombosis and hemostasis, 43 (8), 849–863.
  • Connolly, S.J., et al.,; Committee AS and Investigators. 2011. Apixaban in patients with atrial fibrillation. New England journal of medicine, 364 (9), 806–817.
  • Connolly, S.J., et al.,; Committee R-LS and Investigators. 2009. Dabigatran versus warfarin in patients with atrial fibrillation. New England journal of medicine, 361 (12), 1139–1151.
  • Dauerman, H.L., et al., 2005. Bleeding complications in patients with anemia and acute myocardial infarction. The American journal of cardiology, 96 (10), 1379–1383.
  • Granger, C.B., et al.,; Committees A and Investigators. 2011. Apixaban versus warfarin in patients with atrial fibrillation. New England journal of medicine, 365 (11), 981–992.
  • Hagl, S., et al., 1977. The effect of hemodilution on regional myocardial function in the presence of coronary stenosis. Basic research in cardiology, 72 (4), 344–364.
  • Hariri, E., et al., 2018. Twenty-five-year (1986–2011) trends in the incidence and death rates of stroke complicating acute myocardial infarction. The American journal of medicine, 131 (9), 1086–1094.
  • Kaushik, M.S., et al., 2016. Nitric oxide ameliorates the damaging effects of oxidative stress induced by iron deficiency in cyanobacterium Anabaena 7120. Environmental science and pollution research international, 23 (21), 21805–21821.
  • Kikkert, W.J., et al., 2015. Predictors and prognostic consequence of gastrointestinal bleeding in patients with ST-segment elevation myocardial infarction. International journal of cardiology, 184, 128–134.
  • Kirchhof, P., et al., 2016. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European society of cardiology, 18 (11), 1609–1678.
  • Langston, R.D., et al., 2003. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney international, 64 (4), 1398–1405.
  • Levine, G.N., et al., 2016a. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation, 134, e123-e155.
  • Levine, G.N., et al., 2016b. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention and the 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction. Journal of the American college of cardiology, 67 (10), 1235–1250.
  • Mehran, R., et al., 2010. A risk score to predict bleeding in patients with acute coronary syndromes. Journal of the American college of cardiology, 55 (23), 2556–2566.
  • Merkler, A.E., et al., 2018. Duration of heightened ischemic stroke risk after acute myocardial infarction. Journal of the American heart association, 7 (22), e010782.
  • Nikolsky, E., et al., 2004. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. Journal of the American college of cardiology, 44 (3), 547–553.
  • Shu, D.H., et al., 2006. Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes. Cardiovascular diabetology, 5 (1), 8.
  • Westenbrink, B.D., et al., 2017. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. American heart journal, 185, 140–149.
  • Wu, W.C., et al., 2001. Blood transfusion in elderly patients with acute myocardial infarction. The new England journal of medicine, 345 (17), 1230–1236.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.